Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Stewart Sell. (2019) How vaccines work: immune effector mechanisms and designer vaccines. Expert Review of Vaccines 18:10, pages 993-1015.
Read now
Read now
Alex C. D. Salyer & Sunil A. David. (2018) Transcriptomal signatures of vaccine adjuvants and accessory immunostimulation of sentinel cells by toll-like receptor 2/6 agonists. Human Vaccines & Immunotherapeutics 14:7, pages 1686-1696.
Read now
Read now
Daniela F Hozbor. (2017) Outer membrane vesicles: an attractive candidate for pertussis vaccines. Expert Review of Vaccines 16:3, pages 193-196.
Read now
Read now
Christian Herzog. (2015) Changing from whole-cell to acellular pertussis vaccines would trade superior tolerability for inferior protection. Expert Review of Vaccines 14:8, pages 1065-1072.
Read now
Read now
Antonio Cassone. (2014) Fighting pertussis re-emergence: promise from vaccination in pregnancy. Pathogens and Global Health 108:8, pages 347-348.
Read now
Read now
Jan T Poolman. (2014) Pertussis vaccines. Expert Review of Vaccines 13:9, pages 1067-1069.
Read now
Read now
Articles from other publishers (32)
Xuanxuan Nian, Hongbo Liu, Mengyao Cai, Kai Duan & Xiaoming Yang. (2023) Coping Strategies for Pertussis Resurgence. Vaccines 11:5, pages 889.
Crossref
Crossref
Kathryn M. Edwards, Michael D. Decker & F. Heath Damron. 2023. Plotkin's Vaccines. Plotkin's Vaccines
763
815.e19
.
David J. Dowling, Soumik Barman, Alyson J. Smith, Francesco Borriello, Danielle Chaney, Spencer E. Brightman, Gandolina Melhem, Byron Brook, Manisha Menon, Dheeraj Soni, Simone Schüller, Karthik Siram, Etsuro Nanishi, Hélène G. Bazin, David J. Burkhart, Ofer Levy & Jay T. Evans. (2022) Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination. Scientific Reports 12:1.
Crossref
Crossref
Noorjahan Aibani, Parth Patel, Rachelle Buchanan, Stacy Strom, Kishor M. Wasan, Robert E. W. Hancock, Volker Gerdts & Ellen K. Wasan. (2022)
Assessing the
In Vivo
Effectiveness of Cationic Lipid Nanoparticles with a Triple Adjuvant for Intranasal Vaccination against the Respiratory Pathogen
Bordetella pertussis
. Molecular Pharmaceutics 19:6, pages 1814-1824.
Crossref
Crossref
Mattia Tiboni, Luca Casettari & Lisbeth Illum. (2021) Nasal vaccination against SARS-CoV-2: Synergistic or alternative to intramuscular vaccines?. International Journal of Pharmaceutics 603, pages 120686.
Crossref
Crossref
Céline Vaure, Véronique Grégoire-Barou, Virginie Courtois, Emilie Chautard, Cyril Dégletagne & Yuanqing Liu. (2021) Göttingen Minipigs as a Model to Evaluate Longevity, Functionality, and Memory of Immune Response Induced by Pertussis Vaccines. Frontiers in Immunology 12.
Crossref
Crossref
M. Allison Wolf, Dylan T. Boehm, Megan A. DeJong, Ting Y. Wong, Emel Sen-Kilic, Jesse M. Hall, Catherine B. Blackwood, Kelly L. Weaver, Claire O. Kelly, Caleb A. Kisamore, Graham J. Bitzer, Justin R. Bevere, Mariette Barbier & F. Heath Damron. (2021) Intranasal Immunization with Acellular Pertussis Vaccines Results in Long-Term Immunity to Bordetella pertussis in Mice. Infection and Immunity 89:3.
Crossref
Crossref
Violaine Dubois, Jonathan Chatagnon, Anaïs Thiriard, Hélène Bauderlique-Le Roy, Anne-Sophie Debrie, Loïc Coutte & Camille Locht. (2021) Suppression of mucosal Th17 memory responses by acellular pertussis vaccines enhances nasal Bordetella pertussis carriage. npj Vaccines 6:1.
Crossref
Crossref
Mosley, Radder & HogenEsch. (2019) Genetic Variation in the Magnitude and Longevity of the IgG Subclass Response to a Diphtheria-Tetanus-Acellular Pertussis (DTaP) Vaccine in Mice. Vaccines 7:4, pages 124.
Crossref
Crossref
I. G. Bazhanova, M. V. Britsina, N. U. Mertsalova & M. N. Ozeretskovskaya. (2019) Genetic variability of <i>Bordetella pertussis</i> and its role in vaccine prevention of pertussis. Journal of microbiology, epidemiology and immunobiology 96:4, pages 98-105.
Crossref
Crossref
Daniela Hozbor. 2019. Pertussis Infection and Vaccines. Pertussis Infection and Vaccines
115
126
.
De-Simone SG, Provance DW & Rocha da Silva F. 2018. Pertussis - Disease, Control and Challenges. Pertussis - Disease, Control and Challenges.
Wei Shi, Yiming Kou, Hao Jiang, Feng Gao, Wei Kong, Weiheng Su, Fei Xu & Chunlai Jiang. (2018) Novel intranasal pertussis vaccine based on bacterium-like particles as a mucosal adjuvant. Immunology Letters 198, pages 26-32.
Crossref
Crossref
Saskia van der Lee, Debbie M. van Rooijen, Mary-Lène de Zeeuw-Brouwer, Marjan J. M. Bogaard, Pieter G. M. van Gageldonk, Axel Bonacic Marinovic, Elisabeth A. M. Sanders, Guy A. M. Berbers & Anne-Marie Buisman. (2018) Robust Humoral and Cellular Immune Responses to Pertussis in Adults After a First Acellular Booster Vaccination. Frontiers in Immunology 9.
Crossref
Crossref
Saskia van der Lee, Lotte H. Hendrikx, Elisabeth A. M. Sanders, Guy A. M. Berbers & Anne-Marie Buisman. (2018) Whole-Cell or Acellular Pertussis Primary Immunizations in Infancy Determines Adolescent Cellular Immune Profiles. Frontiers in Immunology 9.
Crossref
Crossref
Saskia van der Lee, Elisabeth A.M. Sanders, Guy A.M. Berbers & Anne-Marie Buisman. (2018) Whole-cell or acellular pertussis vaccination in infancy determines IgG subclass profiles to DTaP booster vaccination. Vaccine 36:2, pages 220-226.
Crossref
Crossref
Kathryn M. Edwards & Michael D. Decker. 2018. Plotkin's Vaccines. Plotkin's Vaccines
711
761.e16
.
Nicolas Burdin, Lori Kestenbaum Handy & Stanley A. Plotkin. (2017) What Is Wrong with Pertussis Vaccine Immunity?. Cold Spring Harbor Perspectives in Biology 9:12, pages a029454.
Crossref
Crossref
Koichiro Suzuki, Naoaki Shinzawa, Keisuke Ishigaki, Keiji Nakamura, Hiroyuki Abe, Aya Fukui-Miyazaki, Kazuyoshi Ikuta & Yasuhiko Horiguchi. (2017)
Protective effects of
in vivo
-expressed autotransporters against
Bordetella pertussis
infection
. Microbiology and Immunology 61:9, pages 371-379.
Crossref
Crossref
Marta V. Pinto & Tod J. Merkel. (2017) Pertussis disease and transmission and host responses: insights from the baboon model of pertussis. Journal of Infection 74, pages S114-S119.
Crossref
Crossref
Charlene M.C. Rodrigues, Marta V. Pinto, Manish Sadarangani & Stanley A. Plotkin. (2017) Whither vaccines?. Journal of Infection 74, pages S2-S9.
Crossref
Crossref
E. M. Zaitsev, A. V. Poddubikov, M. V. Britsina, M. N. Ozeretskovskaya, N. U. Mertsalova & I. G. Bazhanova. (2016) PROFILES OF CYTOKINES IN MICE DURING IMMUNIZATION WITH ADTP-VACCINE WITH ACELLULAR PERTUSSIS COMPONENT. Journal of microbiology, epidemiology and immunobiology 93:6, pages 49-53.
Crossref
Crossref
Simon D. van Haren, David J. Dowling, Willemina Foppen, Dennis Christensen, Peter Andersen, Steven G. Reed, Robert M. Hershberg, Lindsey R. Baden & Ofer Levy. (2016) Age-Specific Adjuvant Synergy: Dual TLR7/8 and Mincle Activation of Human Newborn Dendritic Cells Enables Th1 Polarization. The Journal of Immunology 197:11, pages 4413-4424.
Crossref
Crossref
Nicholas H. Carbonetti, Carl Heinz Wirsing von König, Ruiting Lan, Francoise Jacob-Dubuisson, Peggy A. Cotter, Rajendar Deora, Tod J. Merkel, Cécile A. van Els, Camille Locht, Daniela Hozbor & Maria E. Rodriguez. (2016) Highlights of the 11th International Bordetella Symposium: from Basic Biology to Vaccine Development. Clinical and Vaccine Immunology 23:11, pages 842-850.
Crossref
Crossref
Cristina Bruno, Valentina Agnolon, Francesco Berti, Simone Bufali, Derek T. O’Hagan & Barbara C. Baudner. (2016) The preparation and characterization of PLG nanoparticles with an entrapped synthetic TLR7 agonist and their preclinical evaluation as adjuvant for an adsorbed DTaP vaccine. European Journal of Pharmaceutics and Biopharmaceutics 105, pages 1-8.
Crossref
Crossref
Paul E. Kilgore, Abdulbaset M. Salim, Marcus J. Zervos & Heinz-Josef Schmitt. (2016) Pertussis: Microbiology, Disease, Treatment, and Prevention. Clinical Microbiology Reviews 29:3, pages 449-486.
Crossref
Crossref
Simon D. van Haren, Lakshmi Ganapathi, Ilana Bergelson, David J. Dowling, Michaela Banks, Ronald C. Samuels, Steven G. Reed, Jason D. Marshall & Ofer Levy. (2016) In vitro cytokine induction by TLR-activating vaccine adjuvants in human blood varies by age and adjuvant. Cytokine 83, pages 99-109.
Crossref
Crossref
Jully Gogoi-Tiwari, Vincent Williams, Charlene Babra Waryah, Sangeetha Mathavan, Harish Kumar Tiwari, Paul Costantino & Trilochan Mukkur. (2016) Intramammary Immunization of Pregnant Mice with Staphylococcal Protein A Reduces the Post-Challenge Mammary Gland Bacterial Load but Not Pathology. PLOS ONE 11:2, pages e0148383.
Crossref
Crossref
Kirsi Gröndahl-Yli-Hannuksela, Leni Kauko, Olivier Van Der Meeren, Jussi Mertsola & Qiushui He. (2016) Pertussis specific cell-mediated immune responses ten years after acellular pertussis booster vaccination in young adults. Vaccine 34:3, pages 341-349.
Crossref
Crossref
John C. Hu, Christopher J. Greene, Natalie D. King-Lyons & Terry D. Connell. (2015) The Divergent CD8+ T Cell Adjuvant Properties of LT-IIb and LT-IIc, Two Type II Heat-Labile Enterotoxins, Are Conferred by Their Ganglioside-Binding B Subunits. PLOS ONE 10:11, pages e0142942.
Crossref
Crossref
María Emilia Gaillard, Daniela Bottero, Griselda Moreno, Martin Rumbo & Daniela Hozbor. (2015) Strategies and new developments to control pertussis, an actual health problem: Graphical Abstract Figure.. Pathogens and Disease 73:8, pages ftv059.
Crossref
Crossref
Mark T. Orr, Elyse A. Beebe, Thomas E. Hudson, David Argilla, Po-Wei D. Huang, Valerie A. Reese, Christopher B. Fox, Steven G. Reed & Rhea N. Coler. (2015) Mucosal delivery switches the response to an adjuvanted tuberculosis vaccine from systemic TH1 to tissue-resident TH17 responses without impacting the protective efficacy. Vaccine 33:48, pages 6570-6578.
Crossref
Crossref